ASO Author Reflections: Neoadjuvant Chemotherapy Combined with Immunotherapy is a Promising Strategy for Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

被引：0
|
作者：
Sun, Xiong [1 ]
Lyu, Jianbo [1 ]
Yin, Yuping [1 ]
Tao, Kaixiong [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Hubei, Peoples R China
来源：
ANNALS OF SURGICAL ONCOLOGY | 2024年 / 31卷 / 12期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1245/s10434-024-16152-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：8179 / 8180
页数：2
相关论文
共 50 条
  • [31] ASO Visual Abstract: Influence of Neoadjuvant Immunotherapy-Chemotherapy on Perioperative Outcomes in Locally Advanced Esophageal Adenocarcinoma
    Nevo, Yehonatan
    Tankel, James
    Zao, Henry
    Ramirez, Jaime
    Cools-Lartigue, Jonathan
    Muller, Carmen
    Alcindor, Thierry
    Ferri, Lorenzo
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (09) : 5775 - 5775
  • [32] A randomized phase II trial of neoadjuvant chemotherapy compared with chemoradiotherapy in locally advanced gastroesophageal and gastric adenocarcinoma
    Jin, J.
    Wang, X.
    Zhao, D. B.
    Chi, Y.
    Zhao, H.
    Yang, L.
    Zhou, A. P.
    Jiang, L. M.
    Tang, Y.
    Ren, H.
    Li, N.
    Liu, W. Y.
    Li, Y. X.
    ANNALS OF ONCOLOGY, 2015, 26 : 69 - 69
  • [33] Camrelizumab combined with FLOFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: Updated results of efficacy and safety.
    Liu, Ying
    Han, Guangsen
    Li, Hongle
    Zhao, Yuzhou
    Li, Zhi
    Zhuang, Jing
    Wang, Gangcheng
    Li, Baodong
    Wang, Jinbang
    Li, Zhimeng
    Xia, Qingxin
    Zhang, Chengjuan
    Yu, Juan
    Li, Ke
    Xu, Shuning
    Qiao, Lei
    Kuang, Gaizhen
    Li, Danyang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma
    Anne E. O’Shea
    Elizabeth L. Carpenter
    Daniel W. Nelson
    Timothy J. Vreeland
    Annals of Surgical Oncology, 2022, 29 : 6029 - 6030
  • [35] ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma
    O'Shea, Anne E.
    Carpenter, Elizabeth L.
    Nelson, Daniel W.
    Vreeland, Timothy J.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (09) : 6029 - 6030
  • [36] Locally advanced gastroesophageal junction cancer: Neoadjuvant treatment with VMAT and concomitant chemotherapy
    Tozzi, A.
    Iftode, C.
    Comito, T.
    Campisi, M. C.
    Navarria, P.
    Clerici, E.
    Maggi, G.
    Mancosu, P.
    Stravato, A.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S69 - S69
  • [37] Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: A phase II study
    Newman, E
    Potmesil, M
    Ryan, T
    Marcus, S
    Hiotis, S
    Yee, H
    Norwood, B
    Wendell, M
    Muggia, F
    Hochster, H
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S97 - S100
  • [38] Two-Year Outcomes and Biomarker Analysis of Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma After Neoadjuvant Chemotherapy and Immunotherapy from the Phase II WuhanUHGI001 Trial
    Sun, Xiong
    Lyu, Jianbo
    Yang, Ming
    Lin, Yao
    Wu, Ke
    Liu, Ke
    Li, Anshu
    Shuai, Xiaoming
    Cai, Kailin
    Wang, Zheng
    Wang, Guobin
    Zhang, Peng
    Yin, Yuping
    Tao, Kaixiong
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (12) : 8157 - 8169
  • [39] Neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: Our experience in the elderly
    Bugiantella W.
    Cavazzoni E.
    Elia E.
    Evoli L.
    Graziosi L.
    Mingrone E.
    Donini A.
    BMC Geriatrics, 9 (Suppl 1)
  • [40] ASO Author Reflections: Prediction of the Chemotherapy Effect on the Prognosis of Locally Advanced Pancreatic Cancer
    Tanaka, Masayuki
    Hackert, Thilo
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2409 - 2410
12345